AmerisourceBergen Launches Innovation Cancer to Support Independent Oncology

January 28, 2016

Chesterbrook, Pa. – Today, AmerisourceBergen announced the launch of Innovation Cancer, a community of independent oncologists from across the nation that utilizes business intelligence tools and other resources that enable their practices to focus on providing the highest quality of care. Innovation Cancer offers access to business coaching and technology designed to improve practice efficiency, as well as marketing capabilities to help make patients more aware of their choices in where to receive treatment.

“Patients should have a choice when it comes to making decisions about where to receive care, including independent oncologists that provide compassionate, personalized care, close to home,” said Vicki Albrecht, Vice President, Strategy for Provider Solutions at AmerisourceBergen Specialty Group. “The launch of Innovation Cancer is indicative of our continued support of patients and the providers – large and small – that offer exceptional care and treatment.”

Innovation Cancer’s suite of offerings for oncology practices includes:

  • A 360-degree assessment of practice operations and the patient experience to identify areas of improvement
  • InfoDive, a business intelligence solution, uses advanced data analytics to detect meaningful trends that allow practices to become more efficient and deliver higher-quality care
  • Ongoing business coaching to help improve efficiencies across practices and grow the business
  • Access to turnkey marketing resources built to increase awareness of independent practices in the competitive oncology marketplace

These solutions aim to reduce practice costs, increase scheduling and practice flow to allow for more patient visits per month, improve claim accuracy, reduce denials and identify inaccurate billing.

“Partnering with Innovation Cancer has enabled our practice to function more efficiently and effectively,” said Dr. Kenneth Blankstein, MD, of Hunterdon HEM/ONC, LLC, a participant in Innovation Cancer’s pilot program. “As a result, we’re able to stay focused on driving quality outcomes for our patients by providing personalized and advanced care right in their communities.”

For more information about becoming an Innovation Cancer member practice, please email info@innovationcancer.com.   

About AmerisourceBergen            
                                                              
AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health. With over $135 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 18,000 people. AmerisourceBergen is ranked #16 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com